Clinical Trial Update: A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence [NA]

View source ↗

Summary

Completed feasibility trial investigating the effect of concomitant renal denervation and cardiac ablation on atrial fibrillation recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Cardiac ablation (cardiac ablation)
• Renal denervation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2020-05-22